Drew Kelso

Drew Kelso currently serves as Associate Director and previously held roles as Senior Scientist and Scientist II at Life Edit Therapeutics since June 2021, focusing on DNA repair factors in genome maintenance as potential cancer therapeutic targets. Prior experience includes a Scientist role at Intellia Therapeutics, a Postdoctoral Research Fellow at City of Hope, and an Adjunct Professor position at Azusa Pacific University teaching General Biology I Laboratory. Drew also contributed as a Project Consultant at ChromoLogic, a Graduate Research Assistant at Clemson University, and a Laboratory Technician at LabCorp, among other roles. Drew holds a PhD in Biochemistry and Molecular Biology from Clemson University, a Certificate in Bioscience Management from Keck Graduate Institute, an MS in Biotechnology from the University of Alabama at Birmingham, and a BS in Biology from the University of Montevallo.